Skip to main content
Daito Pharmaceutical Co., Ltd. logo

Daito Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 4577 ISIN · JP3486150000 T Manufacturing
Open in API
Filings indexed 73 across all filing types
Latest filing 2026-04-10 Transaction in Own Shar…
Country JP Japan
Listing T 4577

About Daito Pharmaceutical Co., Ltd.

https://www.eng.daitonet.co.jp/

Daito Pharmaceutical Co., Ltd. is a manufacturer specializing in the integrated production of pharmaceuticals, from active pharmaceutical ingredients (APIs) to finished formulation products. The company's core activities include the development and supply of APIs, primarily for generic drugs, and the manufacturing of generic and over-the-counter (OTC) medications. Additionally, Daito provides contract manufacturing services for various pharmaceutical products. The company emphasizes a comprehensive quality assurance system to ensure the stable supply of high-quality products to its clients.

Recent filings

Filing Released Lang Actions
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 1% confidence The document is a ‘自己株券買付状況報告書’ filed under Article 24-6 of the Financial Instruments and Exchange Act, detailing the company’s own share repurchase (quantity, dates, totals) for the period. This clearly matches a Transaction in Own Shares report.
2026-04-10 Japanese
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 1% confidence The document is a 'Report on Status of Purchase of Treasury Shares' (自己株券買付状況報告書) filed under Article 24-6, Paragraph 1 of the Financial Instruments and Exchange Act of Japan. It details the company's share buyback activity for the month of February 2026, including specific dates, number of shares purchased, and total cost. This falls directly under the category of 'Transaction in Own Shares' (POS).
2026-03-12 Japanese
確認書
Regulatory Filings Classification · 1% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under Article 24-5-2 of the Financial Instruments and Exchange Act of Japan. This document serves as a formal certification by the CEO and CFO regarding the accuracy of the contents of the 'Semi-Annual Report' (Hankishō-hokokusho). Since this is a standalone regulatory filing confirming the accuracy of a financial report rather than the report itself, and it is a specific regulatory requirement in Japan, it falls under the category of Regulatory Filings.
2026-01-14 Japanese
半期報告書－第84期(2025/06/01－2025/11/30)
Interim / Quarterly Report Classification · 1% confidence The document is a '半期報告書' (Semi-Annual Report) filed by Daito Pharmaceutical Co., Ltd. under the Financial Instruments and Exchange Act of Japan. It contains comprehensive financial statements, including the balance sheet, income statement, and cash flow statement for the interim period ending November 30, 2025. As it is a formal, comprehensive financial report for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. H1 2026
2026-01-14 Japanese
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 1% confidence The document is a 'Report on Status of Purchase of Treasury Shares' (自己株券買付状況報告書) filed under Article 24-6, Paragraph 1 of the Financial Instruments and Exchange Act of Japan. It details the specific dates, quantities, and prices of the company's own share repurchases during the month of December 2025. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS), which covers reports of a company buying back its own shares.
2026-01-13 Japanese
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 1% confidence The document is a 'Report on Status of Purchase of Treasury Shares' (自己株券買付状況報告書) filed under Article 24-6, Paragraph 1 of the Financial Instruments and Exchange Act of Japan. It details the specific dates, quantities, and monetary values of shares repurchased by Daito Pharmaceutical Co., Ltd. during the month of November 2025. This document type is specifically defined as 'Transaction in Own Shares' (POS) in the provided classification schema.
2025-12-11 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.